检索结果-南通市图书馆

HER2 testing in gastric cancer: An update

World Journal of Gastroenterology 2016年第19期22卷 4619-4625页

作者： Lucas Faria Abrahao-Machado cristovam scapulatempo-neto Department of Pathology Barretos Cancer Hospital

Human epidermal growth factor receptor 2(HER2) overexpression is increasingly recognized as a frequent molecular abnormality in gastric and gastroesophageal cancer. With the recent introduction of HER2 molecular targeted therapy for patients with advanced gastric cancer, determination of HER2 status is crucial in order to select patients who may benefit from this treatment. This paper provides an update on our knowledge of HER2 in gastric and gastroesophageal cancer, including the prognostic relevance of HER2, the key differences between HER2 protein expression interpretation in breast and gastric cancer, the detection methods and the immunohistochemistry scoring system.

关键词： Human epidermal growth factor receptor 2 testing Gastric cancer Immunohistochemistry Scoring system Trastuzumab

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Serrated pathway in colorectal carcinogenesis

引用

World Journal of Gastroenterology 2014年第10期20卷 2634-2640页

作者： Letícia Yamane cristovam scapulatempo-neto Rui Manuel Reis Denise Peixoto Guimares Molecular Oncology Research Center Barretos Cancer Hospital Department of Pathology Barretos Cancer Hospital Life and Health Sciences Research Institute (ICVS) School of Health Sciences University of Minho Department of Endoscopy Barretos Cancer Hospital

Serrated adenocarcinoma is a recently described subset of colorectal cancer(CRC),which account for about10%of all CRCs and follows an alternative pathway in which serrated polyps replace the traditional adenoma as the precursor lesion to *** polyps form a heterogeneous group of colorectal lesions that includes hyperplastic polyps(HPs),sessile serrated adenoma(SSA),traditional serrated adenoma(TSA)and mixed *** are the most common serrated polyp followed by SSA and *** distinct histogenesis is believed to have a major influence in prevention strategies,patient prognosis and therapeutic ***,serrated polyps exhibited also a distinct pattern,with KRAS and BRAF having an important contribution to its *** other molecular changes that have been implicated in the serrated pathway include microsatellite instability and the CpG island methylator *** the present review we will address the current knowledge of serrated polyps,clinical pathological features and will update the most recent findings of its molecular *** understanding of their biology and malignancy potential is imperative to implement a surveillance approach in order to prevent colorectal cancer development.

关键词： Serrated pathway Colorectal carcinogenesis Mutation Microsatellite instability CpG island methylator phenotype

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

HER2 in gastric cancer: Comparative analysis of three different antibodies using whole-tissue sections and tissue microarrays

引用

World Journal of Gastroenterology 2013年第38期19卷 6438-6446页

作者： Lucas Faria Abraho-Machado Alexandre Andrade dos Anjos Jácome Durval Renato Wohnrath José Sebastio dos Santos Estela Cristina Carneseca José Humberto Tavares Guerreiro Fregnani cristovam scapulatempo-neto Department of Pathology Barretos Cancer HospitalBarretosSao Paulo 14784-400Brazil Department of Clinical Oncology Mater Dei HospitalBelo HorizonteMinas Gerais 30140-092Brazil Department of Gastrointestinal Surgical Oncology Barretos Cancer HospitalBarretosSao Paulo 14784-400Brazil Department of Surgery and Anatomy University of S o Paulo-Ribeir o Preto School of MedicineRibeir o PretoSao Paulo 14049-900Brazil Biostatistician at Cancer Registry Department Barretos Cancer HospitalBarretosSao Paulo 14784-400Brazil Researcher Support Center Barretos Cancer HospitalBarretosSao Paulo 14784-400Brazil

AIM:To compare the performance of three commercially available anti-human epidermalgrowth factor receptor 2(HER2)antibodies in whole-tissue sections and tissue microarrays(TMAs)of a series of gastric ***:We present a comparative analysis of three anti-HER2 antibodies(HercepTest,4B5 and SP3)using TMA and whole-tissue sections prepared from the same paraffin blocks of 199 gastric adenocarcinomas operated upon between January 2004 and December2008 at a Brazilian cancer *** data on the patients’age,sex,the anatomical location of the tumor and the Lauren’s histological classification were collected from clinical and pathological *** immunohistochemical(IHC)results were examined by two pathologists and the cases were classified as positive(3+),equivocal(2+)and negative(0 or 1+),according to the criteria of the IHC scoring system of gastric *** and whole-tissue sections were evaluated separately and *** cases yielding discordant IHC results and/or scored as 2+were subjected to dual-color in situ hybridization in order to determine the final HER2 *** determining the sensitivity and predictive value for HER2-positive status,we measured the accuracy of each antibody by calculating the area under the receiver operating characteristic(ROC)*** agreement between the results obtained using the TMAs and those obtained using the whole-tissue sections was assessed by means of Kappa ***:Intratumoral heterogeneity of HER2 expression was observed with all ***2-positive expression(3+)in the whole-tissue sections was observed in 23 cases(11.6%)using the 4B5 antibody,in 18 cases(9.1%)using the SP3 antibody and in 10 cases(5.1%)using the HercepTest *** the TMAs,11 positive cases(5.6%)were identified using SP3 antibody,9(4.6%)using the 4B5 antibody and 6(3%)using the HercepTest *** sensitivity using whole-tissue sections and TMA,respectively,was 95.2%and 42.9%with 4B5,90.5%and 66.7%

关键词： Gastric cancer Human epidermalgrowth factor receptor 2 Immunohistochemistry Whole-tissue sections Tissue microarray Trastuzumab

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Evaluation of HPV Molecular Tests in Primary Screening for Cervical Cancer in Brazil

引用

Open Journal of Obstetrics and Gynecology 2014年第8期4卷 470-478页

作者： José E.Levi Adhemar Longatto-Filho José Eluf-neto Célia L.Rodrigues Cristina M.Oliveira Adriana C.Carloni Adriana T.Lorenzi Maricy Tacla José H.Fregnani Alexandre M.Ab’Saber cristovam scapulatempo Luisa LVilla National Institute of Science and Technology for the Diseases Associated to Papillomaviruses(INCT-HPV) Sao PauloBrazil Virology Lab Tropical Medicine InstituteUniversidade de Sao PauloSao PauloBrazil Laboratory of Medical Investigation(LIM)14 Faculdade de MedicinaUniversidade de Sao PauloSao PauloBrazil ICVS/3B’s-PT Government Associate Laboratory Life and Health Sciences Research Institute(ICVS)School of Health SciencesUniversity of MinhoBragaPortugal Molecular Oncology Research Center Pio XII FoundationBarretosBrazil Department of Preventive Medicine Faculdade de MedicinaUniversidade de Sao PauloSao PauloBrazil Department of Infectious Diseases Faculdade de MedicinaUniversidade de Sao PauloSao PauloBrazil Department of Ginecology and Obstetrics Faculdade de MedicinaUniversidade de São PauloSao PauloBrazil Center for the Researcher Support Pio XII FoundationBarretos Cancer HospitalBarretosBrazil Department of Pathology Faculdade de MedicinaUniversidade de Sao PauloSao PauloBrazil Department of Radiology Center on Translational Oncology InvestigationSao Paulo State Cancer InstituteFaculdade de MedicinaUniversidade de Sao PauloSao PauloBrazil Santa Casa de Sao Paulo Medical School Sao PauloBrazil

Background: Incorporation of HPV tests into cervical cancer screening programs may be advantageous over conventional cytology, especially in developing nations, where the largest burden of cervical cancer is observed. Objectives: To conduct an evaluation of commercially available molecular HPV tests in Brazilian women. Study design: Two groups were recruited: group A was composed of 511 women referred to the clinics because of a previous abnormal Pap test while group B consisted of 2464 subjects under routine screening. Cervical samples were collected using SurePath liquid cytology (LBC) device, and split into aliquots which were submitted to molecular testing by Hybrid Capture and cobas HPV. Colposcopy and biopsies were made according to the standard guidelines, directed by cytological diagnosis. Results: Prevalence of HSIL was 5.97% and 0.7% in Group A and B respectively. High-Risk HPV DNA was found in about 9% of group B women, while in group A this frequency was 24%. Having CIN3+ as the study end-point, the negative predictive values for molecular methods were above 99.8%. All “in-situ” and invasive cervical carcinomas were detected by both HPV nucleic acid assays. Conclusion: Use of HPV DNA testing was feasible and highly sensitive in cancer screening settings of Brazil.

关键词： High-Risk HPV Test HPV-DNA Cervical Cancer Screening

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

欢迎您,

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

在线全文

在线全文

请选择保存的检索档案：

请选择收藏分类：

通借通还

欢迎您,

建议与咨询 留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

在线全文

在线全文

请选择保存的检索档案： 新增检索档案 确定 取消

请选择收藏分类： 新增自定义分类 确定 取消

通借通还

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

请选择保存的检索档案：

请选择收藏分类：